Mutaprodenafil |
|
| Synonyms: rel-5-[5-[[(3R,5S)-3,5-dimethyl-1-piperazinyl]sulfonyl]-2-ethoxyphenyl]-1-methyl-7-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-3-propyl-1H-pyrazolo[4,3-d]pyrimidine; | |
| Cat. No.: S40014 | CAS No.: 1387577-30-1 |
| MDL.: | Formula: C27H35N9O5S2 |
| F.W.629.75 | Purity: 99% |
| Storage: Refrigerator | |
|   | |
| Catalog Number: | S40014 | CAS No.: | 1387577-30-1 | |
| MDL: | Formula: | C27H35N9O5S2 | ||
| F.W.: | 629.75 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | Pale Yellow Solid | M.P.: | >215°C (dec.) | |
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | Chloroform, Methanol | Stability: | ||
| Storage: | Refrigerator | Category: | Reference Standard | |
| Reference: | Terrett, N.K., et al.: Bioorg. Med. Chem. Lett., 6, 1819 (1996), Goldstein, I., et al.: N. Engl. J. Med., 338, 1397 (1998), Demizu, Y. et al.: Chem. Pharm. Bull., 59, 1314 (2011); | |||
| Application: | Mutaprodenafil is a dietary supplement and an illegal analog of Sildenafil ; an orally active selective type 5 cGMP phosphodiesterase inhibitor. | |||
| Category: | Pharmaceuticals, Intermediates & Fine Chemicals | |||








